# Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease

> **NCT00530270** · PHASE3 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 12 (actual)

## Conditions studied

- Anemia, Sickle Cell

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00530270
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-11
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study was closed June 23, 2008 due to low enrollment.
- **Last updated:** 2013-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530270, "Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00530270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*